Drug intelligence / Profile preview

tianmeng capsule

Development stage: Unknown
Lead developer: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Modality: Small Molecules
Administration: Oral

Overview

Tianmeng Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Institute of Basic Clinical Medicine at the China Academy of Chinese Medical Sciences. It is primarily indicated for the treatment of insomnia syndrome. As a TCM product, it typically consists of a multi-ingredient herbal combination designed to regulate sleep patterns and address systemic imbalances associated with sleep disorders. The drug has been evaluated in randomized, double-blind, placebo-controlled Phase 4 clinical trials (such as ChiCTR-TRC-10000856) to verify its clinical effectiveness and safety in patients suffering from insomnia.

Brand names: Tianmeng Capsule
Other names: Tianmeng Jiaonang

Targets

MTNR1A (MT1)

Beyond the preview

Go deeper on tianmeng capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tianmeng capsule.

Explore the full profile